Dai Xiaofeng, Bazaka Kateryna, Thompson Erik W, Ostrikov Kostya Ken
Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Wuhan Ammunition Life-Tech Company, Ltd., Wuhan 430200, China.
Cancers (Basel). 2020 Nov 13;12(11):3360. doi: 10.3390/cancers12113360.
Rich in reactive oxygen and nitrogen species, cold atmospheric plasma has been shown to effectively control events critical to cancer progression; selectively inducing apoptosis, reducing tumor volume and vasculature, and halting metastasis by taking advantage of, e.g., synergies between hydrogen peroxide and nitrites. This paper discusses the efficacy, safety and administration of cold atmospheric plasma treatment as a potential tool against cancers, with a focus on the mechanisms by which cold atmospheric plasma may affect critical transitional switches that govern tumorigenesis: the life/death control, tumor angiogenesis and epithelial-mesenchymal transition, and drug sensitivity spectrum. We introduce the possibility of modeling cell transitions between the normal and cancerous states using cold atmospheric plasma as a novel research avenue to enhance our understanding of plasma-aided control of oncogenesis.
冷大气等离子体富含活性氧和氮物种,已被证明能有效控制对癌症进展至关重要的事件;通过利用例如过氧化氢和亚硝酸盐之间的协同作用,选择性地诱导细胞凋亡、减小肿瘤体积和血管生成,并阻止转移。本文讨论了冷大气等离子体治疗作为一种潜在抗癌工具的疗效、安全性和给药方式,重点关注冷大气等离子体可能影响控制肿瘤发生的关键转变开关的机制:生死控制、肿瘤血管生成和上皮-间质转化,以及药物敏感性谱。我们介绍了利用冷大气等离子体模拟正常状态和癌状态之间细胞转变的可能性,以此作为一种新的研究途径,以加深我们对等离子体辅助控制肿瘤发生的理解。